Lista de

Adenocarcinoma
52
"RUNX1 and FOXP3 interplay regulates expression of breast cancer related genes" (2016) Recouvreux, M.S.;Grasso, E.N.;Echeverria, P.C. (...)Rubinstein, N. Oncotarget. 7(6):6552-6565
"RUNX1 and FOXP3 interplay regulates expression of breast cancer related genes" (2016) Recouvreux, M.S.;Grasso, E.N.;Echeverria, P.C. (...)Rubinstein, N. Oncotarget. 7(6):6552-6565
"Cytotoxic tirucallane triterpenoids from Melia azedarach fruits" (2010) Ntalli, N.G.;Cottiglia, F.;Bueno, C.A. (...)Caboni, P. Molecules. 15(9):5866-5877
"Cytotoxic tirucallane triterpenoids from Melia azedarach fruits" (2010) Ntalli, N.G.;Cottiglia, F.;Bueno, C.A. (...)Caboni, P. Molecules. 15(9):5866-5877
"Dolabellane diterpenoids from the south atlantic gorgonian convexella magelhaenica" (2010) Rojo De Almeida, M.T.;Siless, G.E.;Perez, C.D. (...)Palermo, J.A. Journal of Natural Products. 73(10):1714-1717
"Dolabellane diterpenoids from the south atlantic gorgonian convexella magelhaenica" (2010) Rojo De Almeida, M.T.;Siless, G.E.;Perez, C.D. (...)Palermo, J.A. Journal of Natural Products. 73(10):1714-1717
"Cellular inactivation and antitumor efficacy of a new zinc phthalocyanine with potential use in photodynamic therapy" (2008) Vittar, N.B.R.;Prucca, C.G.;Strassert, C. (...)Rivarola, V.A. International Journal of Biochemistry and Cell Biology. 40(10):2192-2205
"Fibronectin is distinctly downregulated in murine mammary adenocarcinoma cells with high metastatic potential" (2006) Urtreger, A.J.;Werbajh, S.E.;Verrecchia, F. (...)Bal De Kier Joffé, E.D. Oncology Reports. 16(6):1403-1410
"Fibronectin is distinctly downregulated in murine mammary adenocarcinoma cells with high metastatic potential" (2006) Urtreger, A.J.;Werbajh, S.E.;Verrecchia, F. (...)Bal De Kier Joffé, E.D. Oncology Reports. 16(6):1403-1410
"Sensitivity to ALA-PDT of cell lines with different nitric oxide production and resistance to NO cytotoxicity" (2005) Di Venosa, G.;Perotti, C.;Fukuda, H. (...)Casas, A. Journal of Photochemistry and Photobiology B: Biology. 80(3):195-202
"Sensitivity to ALA-PDT of cell lines with different nitric oxide production and resistance to NO cytotoxicity" (2005) Di Venosa, G.;Perotti, C.;Fukuda, H. (...)Casas, A. Journal of Photochemistry and Photobiology B: Biology. 80(3):195-202
"Herpes simplex virus thymidine kinase/ganciclovir system in multicellular tumor spheroids" (2004) Finocchiaro, L.M.E.;Bumaschny, V.F.;Karara, A.L. (...)Glikin, G.C. Cancer Gene Therapy. 11(5):333-345
"Type I insulin-like growth factor receptor antisense strategies in experimental breast cancer " (2004) Salatino, M.;Schillaci, R.;Proietti, C.J. (...)Elizalde, P.V. Medicina. 64(2):129-134
"Mechanistic studies on δ-aminolevulinic acid uptake and efflux in a mammary adenocarcinoma cell line" (2003) Correa García, S.;Casas, A.;Perotti, C. (...)Bermúdez Moretti, M. British Journal of Cancer. 89(1):173-177
"In vitro photosensitisation of a murine mammary adenocarcinoma cell line with Verteporfin." (2002) Casas, A.; Di Venosa, G.; Batlle, A.; Fukuda, H. Cellular and molecular biology (Noisy-le-Grand, France). 48(8):931-937
"In vitro photosensitisation of a murine mammary adenocarcinoma cell line with Verteporfin." (2002) Casas, A.; Di Venosa, G.; Batlle, A.; Fukuda, H. Cellular and molecular biology (Noisy-le-Grand, France). 48(8):931-937
"δ-aminolevulinic acid transport in murine mammary adenocarcinoma cells is mediated by beta transporters" (2002) Bermúdez Moretti, M.;Correa García, S.;Perotti, C. (...)Casas, A. British Journal of Cancer. 87(4):471-474
"Interferon-alpha 2b modulation of doxorubicin sensitivity in a multidrug resistant cell line" (2001) Gritti, M.F.L.; Beviacqua, M.; Bordenave, R.H.; Rumi, L.S. Journal of Experimental and Clinical Cancer Research. 20(3):393-400
"Regulation of HLA-DR antigen in monocytes from colorectal cancer patients by in vitro treatment with human recombinant interferon-γ" (2000) Novellino, P.S.;Trejo, Y.G.;Beviacqua, M. (...)Rumi, L.S. Journal of Investigational Allergology and Clinical Immunology. 10(2):90-93
"Reversal of estrogen-resistance in murine mammary adenocarcinomas" (1999) Montecchia, M.F.; Molinolo, A.; Lanari, C. Breast Cancer Research and Treatment. 54(2):93-99
"Tissue distribution and kinetics of endogenous porphyrins synthesized after topical application of ALA in different vehicles" (1999) Casas, A.; Fukuda, H.; Del C Batlle, A.M. British Journal of Cancer. 81(1):13-18
"Promoter effect of medroxyprogesterone acetate (MPA) in N-methyl-N-nitrosourea (MNU) induced mammary tumors in BALB/c mice" (1998) Pazos, P.;Lanari, C.;Elizalde, P. (...)Molinolo, A.A. Carcinogenesis. 19(3):529-531
"Expression of Hoxa-1 and Hoxb-7 is regulated by extracellular matrix- dependent signals in mammary epithelial cells" (1998) Srebrow, A.;Friedmann, Y.;Ravanpay, A. (...)Bissell, M.J. Journal of Cellular Biochemistry. 69(4):377-391
"Involvement of insulin-like growth factors-I and-II and their receptors in medroxyprogesterone acetate-induced growth of mouse mammary adenocarcinomas" (1998) Elizalde, P.V.;Lanari, C.;Molinolo, A.A. (...)Charreau, E.H. Journal of Steroid Biochemistry and Molecular Biology. 67(4):305-317
"Potentiation of the 5-aminolevulinic acid-based photodynamic therapy with cyclophosphamide" (1997) Casas, A.; Fukuda, H.; Batlle, A.M.D.C. Cancer Biochemistry Biophysics. 16(1):183-196
"Potentiation of the 5-aminolevulinic acid-based photodynamic therapy with cyclophosphamide" (1997) Casas, A.; Fukuda, H.; Batlle, A.M.D.C. Cancer Biochemistry Biophysics. 16(1):183-196
"Induccion de adenocarcinomas mamarios por progestagenos en ratones BALB/c: Progresion del tumor hormono-dependiente al autonomo" (1997) Lanari, C.;Montecchia, M.F.;Pazos, P. (...)Mounolo, A.A. Medicina. 57(SUPPL 2):55-69
"Induccion de adenocarcinomas mamarios por progestagenos en ratones BALB/c: Progresion del tumor hormono-dependiente al autonomo" (1997) Lanari, C.;Montecchia, M.F.;Pazos, P. (...)Mounolo, A.A. Medicina. 57(SUPPL 2):55-69
"Enhancement of aminolevulinic acid based photodynamic therapy by adriamycin" (1997) Casas, A.; Fukuda, H.; Riley, P.; Del C. Batlle, A.M. Cancer Letters. 121(1):105-113
"Detection of endothelial cells by MEC 13.3 monoclonal antibody in mice mammary tumors" (1997) Vanzulli, S.;Gazzaniga, S.;Braidot, M.F. (...)Wainstok De Calmanovici, R. Biocell. 21(1):39-46
"Detection of endothelial cells by MEC 13.3 monoclonal antibody in mice mammary tumors" (1997) Vanzulli, S.;Gazzaniga, S.;Braidot, M.F. (...)Wainstok De Calmanovici, R. Biocell. 21(1):39-46
"Tumor cells engineered to express interleukin-6 exhibit a reduced tumorigenicity depending on the tumor cell model." (1996) Ledda, M.F.;Adris, S.;Bravo, A.I. (...)Podhajcer, O.L. Cellular and molecular biology (Noisy-le-Grand, France). 42(5):769-778
"Tumor cells engineered to express interleukin-6 exhibit a reduced tumorigenicity depending on the tumor cell model." (1996) Ledda, M.F.;Adris, S.;Bravo, A.I. (...)Podhajcer, O.L. Cellular and molecular biology (Noisy-le-Grand, France). 42(5):769-778
"Influence of mast cells on two murine mammary adenocarcinomas" (1996) De Cidre, L.L.;Eijan, A.M.;Bertolesi, G. (...)De Lustig, E.S. Tumor Biology. 17(6):345-353
"Varying patterns of expression of insulin-like growth factors I and II and their receptors in murine mammary adenocarcinomas of different metastasizing ability" (1996) Guerra, F.K.;Eijan, A.M.;Puricelli, L. (...)Elizalde, P.V. International Journal of Cancer. 65(6):812-820
"Correlation of TGF-(si expression with medroxiprogesterone acetate responsiveness in mouse mammary adenocarcinomas" (1995) Elizalde, P.V.;Guerra, F.K.;Gravano, M. (...)Lupu, R. Cancer Investigation. 13(2):173-180
"Heparin receptors in two murine mammary adenocarcinomas with different metastatic ability: relationship with growth inhibition" (1995) Bertolesix, G.E.; de Cidre, L.L.; de Lustig, E.S.; Eiján, A.M. Cancer Letters. 90(2):123-131
"Growth inhibition in vitro of murine mammary adenocarcinoma cells by heparin and chemically modified heparins" (1994) Bertolesi, G.E.; De Cidre, L.L.; Eiján, A.M. Tumor Biology. 15(5):275-283
"Photodynamic action of endogenously synthesized porphyrins from aminolevulinic acid, using a new model for assaying the effectiveness of tumoral cell killing" (1993) Fukuda, H.;Casas, A.;Chueke, F. (...)Batlle, A.M.C. International Journal of Biochemistry. 25(10):1395-1398
"Interaction of the -170 cyclic AMP response element with the adjacent CCAAT box in the human fibronectin gene promoter" (1992) Muro, A.F.; Bernath, V.A.; Kornblihtt, A.R. Journal of Biological Chemistry. 267(18):12767-12774
"Studies to determine the possible antitumoral properties of Cobra venom and of Crotoxin Complex A and B" (1988) Baldi, A.;Mordoh, J.;Medrano, E.E. (...)Rumi, L. Medicina. 48(4):337-344
"Studies to determine the possible antitumoral properties of Cobra venom and of Crotoxin Complex A and B" (1988) Baldi, A.;Mordoh, J.;Medrano, E.E. (...)Rumi, L. Medicina. 48(4):337-344
"Correlation between urokinase-type plasminogen activator production and the metastasizing ability of two murine mammary adenocarcinomas" (1988) Pereyra-Alfonso, S.; Haedo, A.; de Kier Joffe, E.B. International Journal of Cancer. 42(1):59-63